As of 2025-09-15, the Relative Valuation of Landos Biopharma Inc (LABP) is (97.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -526.7%.
The range of the Relative Valuation is (71.14) - (99.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 12.6x | 9.8x |
| Forward P/E multiples | 9.0x - 17.9x | 14.8x |
| Fair Price | (71.14) - (99.82) | (97.84) |
| Upside | -410.2% - -535.3% | -526.7% |
| Date | P/E |